b N-acylated homoserine lactonases are known to inhibit the signaling molecules of the biofilm-forming pathogens. In this study, gold nanoparticles were coated with N-acylated homoserine lactonase proteins (AiiA AuNPs) purified from Bacillus licheniformis. The AiiA AuNPs were characterized by UV-visible spectra, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The synthesized AiiA AuNPs were found to be spherical in shape and 10 to 30 nm in size. Treatment with AiiA protein-coated AuNPs showed maximum reduction in exopolysaccharide production, metabolic activities, and cell surface hydrophobicity and potent antibiofilm activity against multidrug-resistant Proteus species compared to treatment with AiiA protein alone. AiiA AuNPs exhibited potent antibiofilm activity at 2 to 8 M concentrations without being harmful to the macrophages. We conclude that at a specific dose, AuNPs coated with AiiA can kill bacteria without harming the host cells, thus representing a potential template for the design of novel antibiofilm and antibacterial protein drugs to decrease bacterial colonization and to overcome the problem of drug resistance. In summary, our data suggest that the combined effect of the lactonase and the gold nanoparticles of the AiiA AuNPs has promising antibiofilm activity against biofilmforming and multidrug-resistant Proteus species.
Biofilm formation by Proteus species has been reported as a source of catheter-associated urinary tract infection that gives rise to serious complications. Proteus vulgaris, Proteus mirabilis, and Proteus penneri are known to cause urinary tract infections in humans (1). Among the Proteus spp., P. vulgaris is capable of forming crystalline biofilms and generating alkaline urine within 24 h (2). Such biofilm-forming pathogenic bacteria are the major cause of many chronic and recurrent infections, such as periodontitis, endocarditis, chronic otitis, and urinary tract and wound infections (3). Moreover, bacteria that adhere to indwelling medical devices such as intravenous catheters, artificial joints, and cardiac pacemakers or to damaged tissue can cause persistent infections through biofilm formation (2, 4, 5). Mature biofilms of Proteus spp. develop on the surface of uroepithelial cells or catheters; organisms within the mushroom-shaped structure regulate a variety of cellular functions, such as glutamine synthesis, autoinducer 2 (AI-2), cyclic dipeptides, and putrescine synthesis (6-8). Catheter-associated urinary tract infections (CAUTIs) affect more than 400,000 patients per year in the United States (9). Antibiotics used to treat these biofilm-forming pathogens are not active against the recalcitrant biofilms; rather, they target their planktonic counterparts, which create selective pressure on the bacteria, which develop resistance to a particular drug (10). Disrupting the multicellular structure of a Proteus biofilm was proposed as one of the most promising strategies for increasing the sensitivity of path...